Page last updated: 2024-08-24

azalanstat and Granulocytic Leukemia, Chronic

azalanstat has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amata, E; Barbagallo, I; Di Raimondo, F; Dichiara, M; Floresta, G; Intagliata, S; Marrazzo, A; Pittalà, V; Prezzavento, O; Rescifina, A; Romeo, G; Salerno, L; Sorrenti, V; Tibullo, D; Turnaturi, R; Vanella, L	1

Other Studies

1 other study(ies) available for azalanstat and Granulocytic Leukemia, Chronic

Article	Year
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines. European journal of medicinal chemistry, 2018, Oct-05, Volume: 158 Topics: Antineoplastic Agents; Cell Survival; Drug Design; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Heme Oxygenase-1; Humans; Imatinib Mesylate; Imidazoles; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Docking Simulation	2018

Article

Year

Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines.

European journal of medicinal chemistry, 2018, Oct-05, Volume: 158

Topics: Antineoplastic Agents; Cell Survival; Drug Design; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Heme Oxygenase-1; Humans; Imatinib Mesylate; Imidazoles; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Docking Simulation

2018